Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Diabetic Ketoacidosis (DKA) Market Growth in 2025?
The market size for diabetic ketoacidosis (DKA) has witnessed significant expansion in the past years. It is projected to elevate from $2.90 billion in 2024 to $3.16 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.8%. The growth in the previous period can be credited to the rise in diabetes cases, delayed detection of type 1 diabetes, inadequate adherence to insulin therapy, heightened obesity rates, and a deficiency in diabetes awareness programs.
What Is the Forecast for the Diabetic Ketoacidosis (DKA) Market Size Through 2029?
Predicted growth in the diabetic ketoacidosis (DKA) market is robust, with estimations indicating an increase up to $4.37 billion by 2029, at a compound annual growth rate (CAGR) of 8.5%. This growth trajectory can be traced back to improvement in insulin delivery systems, higher prevalence of continuous glucose monitoring, rise in the awareness of diabetes-related complications, the expansion of telemedicine in diabetes care, and the growth in healthcare expenditure. The upcoming trends within this period include the incorporation of artificial intelligence in managing diabetes, the creation of closed-loop insulin delivery systems, personalized healthcare, advanced technological tools, and innovative therapeutic approaches.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21168&type=smp
What are the Key Market Players in Diabetic Ketoacidosis (DKA) Market and How They’re Evolving?
Major companies operating in the diabetic ketoacidosis (DKA) market are Merck And Co. Inc., Pfizer Inc., Sanofi S.A., Bristol Myers Squibb, Novartis AG, Roche Holding AG, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., B. Braun Medical Inc., Fresenius Kabi, Merit Pharmaceutical, Oramed Pharmaceuticals Inc., ICU Medical Inc., Tonghua Dongbao Pharmaceutical Co. Ltd., Wockhardt Ltd., Biocon Limited
What Are the Primary Growth Drivers in the Diabetic Ketoacidosis (DKA) Market?
The expansion of the diabetic ketoacidosis (DKA) market is being fuelled by the growing epidemic of obesity. Defined as a health condition marked by an over accumulation of body fat, obesity can detrimentally affect health and escalate the likelihood of numerous diseases. The escalating rates of obesity can be attributed to a cocktail of factors that include unhealthy diet patterns, packed with processed foods, sugars, and fat, physical inactivity due to sedentary lifestyle, excessive screen time, and sociodemographic factors like the availability of economically accessible healthy food and healthcare services. The surge in obesity enhances the risk of developing diabetic ketoacidosis (DKA) as it fosters insulin resistance and aids the onset of type 2 diabetes, which can lead to inadequate blood sugar regulation and successive incidents of DKA. For example, the Switzerland-based World Health Organization (WHO) disclosed in March 2024 that approximately one in eight individuals globally were grappling with obesity. The figure encompassed 2.5 billion adults (those 18 years and above) considered overweight, with 890 million among them living with obesity. Within the adult demographic, 43% were overweight, and 16% were classified as obese. In addition to this, the count of overweight children under five years stood at 37 million. Thus, the escalating trend of obesity is propelling the diabetic ketoacidosis market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21168&type=smp
What Are the Leading Segments in the Global Diabetic Ketoacidosis (DKA) Industry?
The diabetic ketoacidosis (DKA) market covered in this report is segmented –
1) By Type: Pediatric Diabetic Ketoacidosis, Adult Diabetic Ketoacidosis
2) By Treatment Type: Fluid Replacement, Electrolyte Replacement, Insulin Therapy, Intermediate-Acting Insulin, Long-Acting Insulin
3) By Route of Administration: Oral, Parenteral, Other
4) By Distribution Channel: Online Channel, Offline Channel
5) By End Use: Hospitals, Ambulatory Care Center, Specialty Clinics
Subsegments:
1) By Pediatric Diabetic Ketoacidosis: Mild Pediatric DKA, Moderate Pediatric DKA, Severe Pediatric DKA
2) By Adult Diabetic Ketoacidosis: Mild Adult DKA, Moderate Adult DKA, Severe Adult DKA
What Are the Key Market Trends in the Diabetic Ketoacidosis (DKA) Industry?
The focus of leading businesses in the diabetic ketoacidosis market is now on the creation of cutting-edge technologies such as continual glucose monitoring devices. These tools are aimed at enhancing early recognition, managing blood sugar and ketone levels more efficiently, and ultimately decreasing the occurrence and seriousness of DKA episodes among people with diabetes. A continual glucose monitor (CGM) is a device that tracks glucose levels in the body constantly, offering up-to-the-minute data to aid people with diabetes in managing their blood sugar levels. For example, Abbott Laboratories, an American medical device firm, released a novel glucose-ketone monitoring system in June 2022 to simultaneously track both glucose and ketone levels in real-time. This system provides a comprehensive picture of a patient’s metabolic status by tracking both glucose and ketones, allowing for the early identification of potential diabetic problems such as diabetic ketoacidosis (DKA) before they escalate. The system is designed for continual monitoring, providing users with regular data updates without needing manual testing.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/diabetic-ketoacidosis-dka-global-market-report
What Is the Regional Outlook for the Diabetic Ketoacidosis (DKA) Market?
North America was the largest region in the diabetic ketoacidosis (DKA) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic ketoacidosis (DKA) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21168
This Report Delivers Insight On:
1. How big is the diabetic ketoacidosis (dka) market, and how is it changing globally?
2. Who are the major companies in the diabetic ketoacidosis (dka) market, and how are they performing?
3. What are the key opportunities and risks in the diabetic ketoacidosis (dka) market right now?
4. Which products or customer segments are growing the most in the diabetic ketoacidosis (dka) market?
5. What factors are helping or slowing down the growth of the diabetic ketoacidosis (dka) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model